Sakata K, Akanuma A, Aoki Y, Karasawa K, Nakagawa K, Muta N, Iio M, Mohri N
Department of Radiology, Faculty of Medicine, University of Tokyo, Japan.
Radiat Med. 1989 Nov-Dec;7(6):287-92.
From January 1975 through December 1986, 58 previously untreated patients with primary non-Hodgkin's lymphoma of the head and neck in stages I and II were treated at our department. Thirty-seven patients were classified as stage I and 21 as stage II. Complete local remission was obtained in all cases. The 5-year survival rates were 68% and 79% in stages I and II, respectively. The 5-year survival rates according to site of origin were as follows: Waldeyer's ring 77% and neck lymph node 63%. The 5-year survival rates according to the histological classification of the Working Formulation were 73% intermediate grade malignancy and 63% for high grade malignancy. Chemotherapy combined with radiotherapy was essential, especially for cases in stage II. The 5-year survival rate was 100% for patients with chemotherapy and 71% without chemotherapy. The relapse-free 5-year survival rate was 67% with chemotherapy and 36% without chemotherapy. Most first failures were due to the development of generalized disease and the 5-year survival rate after salvage was 44%.
1975年1月至1986年12月期间,我科对58例未经治疗的I期和II期原发性头颈部非霍奇金淋巴瘤患者进行了治疗。其中37例患者被归类为I期,21例为II期。所有病例均获得了完全局部缓解。I期和II期的5年生存率分别为68%和79%。根据原发部位的5年生存率如下:Waldeyer环为77%,颈部淋巴结为63%。根据工作分类法的组织学分类,中级恶性肿瘤的5年生存率为73%,高级恶性肿瘤为63%。化疗联合放疗至关重要,尤其是II期病例。接受化疗的患者5年生存率为100%,未接受化疗的患者为71%。接受化疗的患者无复发生存率为67%,未接受化疗的患者为36%。大多数首次复发是由于全身性疾病的发展,挽救治疗后的5年生存率为44%。